pirenzepine has been researched along with Pain, Intractable in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Pain, Intractable: Persistent pain that is refractory to some or all forms of treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silberstein, SD | 1 |
| Peres, MF | 1 |
| Hopkins, MM | 1 |
| Shechter, AL | 1 |
| Young, WB | 1 |
| Rozen, TD | 1 |
1 other study available for pirenzepine and Pain, Intractable
| Article | Year |
|---|---|
Olanzapine in the treatment of refractory migraine and chronic daily headache.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Female; Headache Disorders; Humans; Male; Mi | 2002 |